Please login to the form below
migraine
This page shows the latest migraine news and features for those working in and with pharma, biotech and healthcare.
Teva wins FDA OK for crucial migraine drug
Teva wins FDA OK for crucial migraine drug. Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig. ... Teva has secured US approval for migraine drug Ajovy, a key part of new chief execeutive Kåre Schultz's turnaround plan for the
Latest news
-
US insurers can peg access to ICER value reviews
It also recommends when prior authorization should be obtained – for example with the new CGRP inhibitor migraine drugs.
-
First migraine prevention drug to hit European market
First migraine prevention drug to hit European market. European Commission green lights Novartis’Aimovig. ... It was reported that those on Aimovig also experienced significant reductions in their number of migraine days per month.
-
Amgen’s R&D chief Sean Harper retires to seek biotech post
Bradway said two new products – Aimovig (erenumab) for migraine and Sensipar follow-up Parsabiv (etelcalcetide) for chronic kidney disease – had started well, and the quarter was also marked by the launch
-
Novartis follows Pfizer and freezes US prices this year
for diffuse large B-cell lymphoma (DLBCL) and new migraine therapy Aimovig (erenumab).
-
CGRP migraine drugs need prior approval for use, recommends ICER
CGRP migraine drugs need prior approval for use, recommends ICER. Suggests clinicians should confirm that patients have tried other therapies prior to using CGRP inhibitors. ... inhibitors for individuals with chronic migraine and no other available
More from news
Approximately 20 fully matching, plus 128 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2018
III CGRP antibody for the treatment of migraine.
-
The good, the bad and the ugly
Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.
-
The cultural construction of illness
Some years ago, we were asked to advise on marketing a cure for migraines in the UK. ... In this world, migraines were associated with ideas of the overly sensitive, or even hysterical woman, requiring rational male intervention to bring her back to her
-
Ditch the data?
Around one in seven people suffer from migraines, and these can impact severely on quality-of-life. ... When a migraine hits, she needs to shut herself in a dark room in silence.
-
Deal Watch January 2017
1, 000. CoLucid. Lilly. Company acquisition. Lasmiditan for the acute treatment of migraine.
More from intelligence
Approximately 2 fully matching, plus 21 partially matching documents found.
Latest appointments
-
Newron Pharma appoints commercial affairs VP
He brings sales and marketing experience from Johnson &Johnson, and served as franchise marketing director for psychiatry, Parkinson's disease and migraine products at Novartis.
-
Red Door Unlimited appoints new digital strategy head
Prior to joining the agency, Morgan worked on accounts in patient advocacy for cancer immunotherapy, hepatitis C treatments and migraines for Firstlight PR and Hill and Knowlton Strategies.
-
Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer
operations. This includes ensuring the success of current products, such as Sumavel DosePro for migraine, as well as soon to be launched products, such as Zohydro, which is pending FDA approval
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Hanson Zandi
Migraine. Monoclonal antibodies. Respiratory. Women’s Health.
-
Double Communiqué award win for 90TEN
The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:
-
What it takes to win at Cannes Health Lions
As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s
-
90TEN nominated for five Communique Awards including Small Consultancy of the Year
The Allergan “ Migraine Unlocked” campaign is a finalist in Excellence in Communications via a Live Event or Stand-Alone Activity, and an HCV programme for AbbVie has been recognised in the
-
What it takes to win at Cannes Health Lions
As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Featured jobs
-
Sudler London - Account Director
-
Competitive
- Account Director or Senior Account Director
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Sudler London - Senior Medical Writer
-
Competitive
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Account Manager
-
Negotiable
-
Systematic Review Lead- London
-
Negotiable
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Senior Medical Writer
-
Salary is DOE
Subscribe to our email news alerts
- Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
- Innovate UK supports AI drug discovery project worth £1m
- Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
- Superhuman editor wins promotion at Porterhouse Medical
- Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness
- Biotech leaders jump into US free speech debate
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
